Detalhe da pesquisa
1.
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes.
Ann Hematol
; 103(2): 437-442, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38060001
2.
A globally applicable "triple A" risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count.
Am J Hematol
; 98(12): 1829-1837, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37665758
3.
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study.
Blood
; 135(5): 381-386, 2020 01 30.
Artigo
Inglês
| MEDLINE | ID: mdl-31869407
4.
Cerebral venous thrombosis and myeloproliferative neoplasms: A three-center study of 74 consecutive cases.
Am J Hematol
; 96(12): 1580-1586, 2021 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34453762
5.
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases.
Am J Hematol
; 95(2): 156-166, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31721282
6.
Second cancers in MPN: Survival analysis from an international study.
Am J Hematol
; 95(3): 295-301, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31816122
7.
Clinical outcomes under hydroxyurea treatment in polycythemia vera: a systematic review and meta-analysis.
Haematologica
; 104(12): 2391-2399, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31123026
8.
Lymphoproliferative disorders in patients with chronic myeloproliferative neoplasms: A systematic review.
Am J Hematol
; 93(5): 698-703, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29377227
9.
A reappraisal of the benefit-risk profile of hydroxyurea in polycythemia vera: A propensity-matched study.
Am J Hematol
; 92(11): 1131-1136, 2017 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-28699191
10.
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19.
Am J Hematol
; 97(12): E470-E473, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36111658
11.
Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial.
JAMA
; 316(18): 1906-1912, 2016 Nov 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27825009
12.
Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma.
Mod Pathol
; 28(4): 487-97, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25341653
13.
Patterns of presentation and thrombosis outcome in patients with polycythemia vera strictly defined by WHO-criteria and stratified by calendar period of diagnosis.
Am J Hematol
; 90(5): 434-7, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25683038
14.
A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera.
Br J Haematol
; 167(4): 541-6, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25130523
15.
ACE inhibitors and cytoreductive therapy in polycythemia vera.
Blood
; 129(9): 1226-1227, 2017 03 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28028024
16.
Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis.
Blood
; 120(3): 569-71, 2012 Jul 19.
Artigo
Inglês
| MEDLINE | ID: mdl-22700720
17.
Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis).
Blood
; 120(26): 5128-33; quiz 5252, 2012 Dec 20.
Artigo
Inglês
| MEDLINE | ID: mdl-23033268
18.
Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome.
Blood
; 119(10): 2239-41, 2012 Mar 08.
Artigo
Inglês
| MEDLINE | ID: mdl-22246040
19.
A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment.
Blood
; 120(6): 1197-201, 2012 Aug 09.
Artigo
Inglês
| MEDLINE | ID: mdl-22740446
20.
Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation.
Haematologica
; 99(5): 916-21, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24389309